Log In
Print
BCIQ
Print
Print this Print this
 

momelotinib (formerly CYT387)

  Manage Alerts
Collapse Summary General Information
Company Gilead Sciences Inc.
DescriptionJanus kinase-1 (JAK-1) and JAK-2 inhibitor
Molecular Target Janus kinase-1 (JAK-1) ; Janus kinase-2 (JAK-2)
Mechanism of ActionJanus kinase-2 (JAK-2) inhibitor
Therapeutic ModalitySmall molecule

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Get a free BioCentury trial today